What type of study is this?

October 2, 2025Clinical Electroencephalography

Clinical Electroencephalographic Variables Suggesting Extrapyramidal Side Effect Risk

View Full Paper

Ask AI

Bookmark

Authors

FSFrederick A. StruveUniversity of Vermont

Discussion

Member takes

Implication

Analysis shows paroxysmal EEG dysrhythmias increase extrapyramidal symptoms risk in neuroleptically treated patients, suggesting the need for better stratification.

Key Points

Patients with minor paroxysmal EEG dysrhythmias have higher rates of extrapyramidal symptoms than those with normal EEG.
In a sample of 375 psychiatric patients, statistically significant increases in EPS symptoms were observed.
Paroxysmal EEG dysrhythmias are connected to the likelihood of receiving anti-EPS medication during treatment protocols.
Stratifying patient samples by EEG patterns may improve the prediction of pharmacological side effects in future studies.

Cite This Study

Frederick A. Struve (1987) studied this question.

synapsesocial.com/papers/68de70f583cbc991d0a23712 https://doi.org/10.1177/155005948701800405

View Full Paper

Ask AI

Bookmark

Implication

Analysis shows paroxysmal EEG dysrhythmias increase extrapyramidal symptoms risk in neuroleptically treated patients, suggesting the need for better stratification.

Clinical Electroencephalographic Variables Suggesting Extrapyramidal Side Effect Risk

Discussion

Member takes

Implication

Key Points

Cite This Study

Clinical Electroencephalographic Variables Suggesting Extrapyramidal Side Effect Risk

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider